Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 7 min read

This article was created with AI assistance.

Acetaminophen Overdose & NAC for ICU Nurses 2026 — The Antidote That Works If You're Early

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

Acetaminophen is the most common cause of acute liver failure in the developed world, and it is also one of the few poisonings with a genuinely effective antidote. That combination makes it a defining ICU story: a patient who often looks completely well in the first hours can be silently destroying their liver, and the drug that prevents it — N-acetylcysteine — works best the earlier it starts. The nurse who understands why the timeline matters, and who keeps the antidote running on schedule, is directly protecting the patient's liver.

The short version: Acetaminophen itself isn't the poison — in overdose it overwhelms the normal clearance path and a toxic metabolite (NAPQI) destroys liver cells once the body's glutathione runs out. Patients look deceptively well early. The 4-hour acetaminophen level plotted on the Rumack-Matthew nomogram guides treatment for a single acute ingestion. The antidote, N-acetylcysteine (NAC), replenishes glutathione and is highly protective — especially when started within ~8 hours. Give NAC even late, and even for non-acetaminophen liver failure it may help.

Why acetaminophen poisons the liver

At normal doses, most acetaminophen is cleared harmlessly, and a small fraction becomes a reactive metabolite called NAPQI that the liver immediately neutralizes using its stores of glutathione. In overdose, the safe pathways saturate, far more NAPQI is produced, and glutathione is consumed faster than it can be regenerated. Once glutathione is depleted, unopposed NAPQI binds to and kills hepatocytes — centrilobular necrosis. This is why the antidote is so elegant: NAC restores glutathione (and provides other protective effects), letting the liver keep neutralizing NAPQI. It also explains the race against time: the sooner you replenish glutathione, the less liver is lost.

The four stages — and the dangerous calm of stage 1

A single large ingestion tends to move through recognizable phases. The trap is stage 1, when the patient may feel nearly fine and labs are still normal, lulling everyone into underestimating the danger.

StageTimeframeWhat you see
10–24 hOften asymptomatic or mild nausea/vomiting — labs still normal. The deceptive calm.
2~24–72 hRight-upper-quadrant pain, rising AST/ALT, climbing INR — the liver is being injured.
3~72–96 hPeak hepatotoxicity: possible fulminant liver failure, encephalopathy, coagulopathy, acidosis, renal injury.
4~4 days–2 weeksRecovery for survivors — or progression to death/transplant.

Because stage 1 is so quiet, the decision to treat rarely rests on how the patient looks. It rests on the ingestion history and the timed level.

The 4-hour level and the nomogram

For a single, known-time acute ingestion, the key number is the acetaminophen level drawn at least 4 hours after ingestion (levels drawn earlier can still be rising and aren't interpretable on the tool). That value is plotted against time on the Rumack-Matthew nomogram; a level above the treatment line means NAC is indicated. Several situations change the math and lower the threshold to treat: an unknown ingestion time, a staggered ingestion over hours, extended-release products, or a patient who already has elevated transaminases. When in doubt, the safe move is to treat — NAC has a wide safety margin, and missed hepatotoxicity does not.

A "normal-looking" overdose patient is not a reassured patient. The most dangerous moment is a comfortable patient in the first several hours whose level hasn't been checked or whose ingestion time is fuzzy. Do not let a benign exam or a single early level delay the timed 4-hour draw and the decision to start NAC. Every hour past the ~8-hour mark that NAC is delayed, its protective benefit falls.

Running NAC — and not derailing it

N-acetylcysteine can be given IV or orally; the IV regimen is common in the ICU, classically a loaded protocol followed by prolonged infusion, with newer simplified two-bag regimens in some centers. Two practical points matter at the bedside. First, an anaphylactoid reaction (flushing, itching, wheeze, hypotension) can occur early in the IV infusion — it is usually managed by pausing/slowing the infusion and treating symptoms, then resuming, rather than abandoning the antidote. Second, keep the infusion continuous and on schedule; interruptions and pump errors blunt the protection you're trying to deliver. Activated charcoal may be used if the patient presents very early after ingestion and the airway is protected.

Your leverage is time and continuity. Get the timed 4-hour level drawn, push for an early treat/don't-treat decision, start NAC without waiting for the patient to look sick, and then guard the infusion — manage anaphylactoid reactions by slowing rather than stopping, and don't let gaps creep in. Trend the AST/ALT, INR, and renal function, and watch for the acute liver failure picture (encephalopathy, coagulopathy, hypoglycemia, acidosis) that flags the sickest patients.

When the liver is already failing

If a patient presents late or with a massive ingestion and progresses to fulminant hepatic failure, NAC is still given and management overlaps entirely with acute liver failure care: relentless treatment of hypoglycemia, careful attention to rising ammonia and cerebral edema risk, resisting the reflex to "fix" the INR (it's the best marker of liver function), broad infection surveillance, and early contact with a transplant center. The King's College criteria — centered on pH, lactate, INR, creatinine, and encephalopathy grade — help identify who needs transplant evaluation. Some of these patients also need CRRT for renal failure and acidosis.

The nursing bottom line

Acetaminophen overdose kills the liver through a toxic metabolite once glutathione is exhausted, and it does so behind a deceptively calm early phase. The decision to treat a single acute ingestion hinges on the 4-hour level plotted on the Rumack-Matthew nomogram, but unknown timing, staggered ingestions, and elevated transaminases all lower the threshold to treat — when unsure, treat. N-acetylcysteine restores glutathione and is highly protective, most of all when started within about eight hours, and it still has a role late and in liver failure. The nurse's highest-value work is protecting the timeline and the infusion: get the timed level, start NAC early, manage anaphylactoid reactions by slowing rather than quitting, and trend the liver and kidney labs while watching for the failure picture that signals the sickest patients.

Related: Acute liver failure · Salicylate toxicity · CRRT basics · Naloxone

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.